138 related articles for article (PubMed ID: 18053726)
1. Inhibitors of proteases and amide hydrolases that employ an alpha-ketoheterocycle as a key enabling functionality.
Maryanoff BE; Costanzo MJ
Bioorg Med Chem; 2008 Feb; 16(4):1562-95. PubMed ID: 18053726
[TBL] [Abstract][Full Text] [Related]
2. Elucidation of fatty acid amide hydrolase inhibition by potent alpha-ketoheterocycle derivatives from Monte Carlo simulations.
Guimarães CR; Boger DL; Jorgensen WL
J Am Chem Soc; 2005 Dec; 127(49):17377-84. PubMed ID: 16332087
[TBL] [Abstract][Full Text] [Related]
3. In-depth study of tripeptide-based alpha-ketoheterocycles as inhibitors of thrombin. Effective utilization of the S1' subsite and its implications to structure-based drug design.
Costanzo MJ; Almond HR; Hecker LR; Schott MR; Yabut SC; Zhang HC; Andrade-Gordon P; Corcoran TW; Giardino EC; Kauffman JA; Lewis JM; de Garavilla L; Haertlein BJ; Maryanoff BE
J Med Chem; 2005 Mar; 48(6):1984-2008. PubMed ID: 15771442
[TBL] [Abstract][Full Text] [Related]
4. 1-Indol-1-yl-propan-2-ones and related heterocyclic compounds as dual inhibitors of cytosolic phospholipase A(2)alpha and fatty acid amide hydrolase.
Forster L; Ludwig J; Kaptur M; Bovens S; Elfringhoff AS; Holtfrerich A; Lehr M
Bioorg Med Chem; 2010 Jan; 18(2):945-52. PubMed ID: 20005725
[TBL] [Abstract][Full Text] [Related]
5. Mining biologically-active molecules for inhibitors of fatty acid amide hydrolase (FAAH): identification of phenmedipham and amperozide as FAAH inhibitors.
Vincent F; Nguyen MT; Emerling DE; Kelly MG; Duncton MA
Bioorg Med Chem Lett; 2009 Dec; 19(23):6793-6. PubMed ID: 19850474
[TBL] [Abstract][Full Text] [Related]
6. Discovery of novel spirocyclic inhibitors of fatty acid amide hydrolase (FAAH). Part 2. Discovery of 7-azaspiro[3.5]nonane urea PF-04862853, an orally efficacious inhibitor of fatty acid amide hydrolase (FAAH) for pain.
Meyers MJ; Long SA; Pelc MJ; Wang JL; Bowen SJ; Schweitzer BA; Wilcox MV; McDonald J; Smith SE; Foltin S; Rumsey J; Yang YS; Walker MC; Kamtekar S; Beidler D; Thorarensen A
Bioorg Med Chem Lett; 2011 Nov; 21(21):6545-53. PubMed ID: 21924613
[TBL] [Abstract][Full Text] [Related]
7. Fluoride-mediated capture of a noncovalent bound state of a reversible covalent enzyme inhibitor: X-ray crystallographic analysis of an exceptionally potent α-ketoheterocycle inhibitor of fatty acid amide hydrolase.
Mileni M; Garfunkle J; Ezzili C; Cravatt BF; Stevens RC; Boger DL
J Am Chem Soc; 2011 Mar; 133(11):4092-100. PubMed ID: 21355555
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and evaluation of benzothiazole-based analogues as novel, potent, and selective fatty acid amide hydrolase inhibitors.
Wang X; Sarris K; Kage K; Zhang D; Brown SP; Kolasa T; Surowy C; El Kouhen OF; Muchmore SW; Brioni JD; Stewart AO
J Med Chem; 2009 Jan; 52(1):170-80. PubMed ID: 19072118
[TBL] [Abstract][Full Text] [Related]
9. Structure based design of novel irreversible FAAH inhibitors.
Wang JL; Bowen SJ; Schweitzer BA; Madsen HM; McDonald J; Pelc MJ; Tenbrink RE; Beidler D; Thorarensen A
Bioorg Med Chem Lett; 2009 Oct; 19(20):5970-4. PubMed ID: 19765986
[TBL] [Abstract][Full Text] [Related]
10. Reversible competitive α-ketoheterocycle inhibitors of fatty acid amide hydrolase containing additional conformational constraints in the acyl side chain: orally active, long-acting analgesics.
Ezzili C; Mileni M; McGlinchey N; Long JZ; Kinsey SG; Hochstatter DG; Stevens RC; Lichtman AH; Cravatt BF; Bilsky EJ; Boger DL
J Med Chem; 2011 Apr; 54(8):2805-22. PubMed ID: 21428410
[TBL] [Abstract][Full Text] [Related]
11. Fatty acid amide hydrolase inhibitors display broad selectivity and inhibit multiple carboxylesterases as off-targets.
Zhang D; Saraf A; Kolasa T; Bhatia P; Zheng GZ; Patel M; Lannoye GS; Richardson P; Stewart A; Rogers JC; Brioni JD; Surowy CS
Neuropharmacology; 2007 Mar; 52(4):1095-105. PubMed ID: 17217969
[TBL] [Abstract][Full Text] [Related]
12. Binding mode of new (thio)hydantoin inhibitors of fatty acid amide hydrolase: comparison with two original compounds, OL-92 and JP104.
Michaux C; Muccioli GG; Lambert DM; Wouters J
Bioorg Med Chem Lett; 2006 Sep; 16(18):4772-6. PubMed ID: 16844375
[TBL] [Abstract][Full Text] [Related]
13. Design of on-target FAAH inhibitors.
Deutsch DG
Chem Biol; 2005 Nov; 12(11):1157-8. PubMed ID: 16298293
[TBL] [Abstract][Full Text] [Related]
14. Structure-activity relationship studies on 1-heteroaryl-3-phenoxypropan-2-ones acting as inhibitors of cytosolic phospholipase A2α and fatty acid amide hydrolase: replacement of the activated ketone group by other serine traps.
Sundermann T; Hanekamp W; Lehr M
J Enzyme Inhib Med Chem; 2016 Aug; 31(4):653-63. PubMed ID: 26153239
[TBL] [Abstract][Full Text] [Related]
15. Discovery of novel spirocyclic inhibitors of fatty acid amide hydrolase (FAAH). Part 1: identification of 7-azaspiro[3.5]nonane and 1-oxa-8-azaspiro[4.5]decane as lead scaffolds.
Meyers MJ; Long SA; Pelc MJ; Wang JL; Bowen SJ; Walker MC; Schweitzer BA; Madsen HM; Tenbrink RE; McDonald J; Smith SE; Foltin S; Beidler D; Thorarensen A
Bioorg Med Chem Lett; 2011 Nov; 21(21):6538-44. PubMed ID: 21924614
[TBL] [Abstract][Full Text] [Related]
16. Discovery and development of fatty acid amide hydrolase (FAAH) inhibitors.
Seierstad M; Breitenbucher JG
J Med Chem; 2008 Dec; 51(23):7327-43. PubMed ID: 18983142
[No Abstract] [Full Text] [Related]
17. Discovery of boronic acids as novel and potent inhibitors of fatty acid amide hydrolase.
Minkkilä A; Saario SM; Käsnänen H; Leppänen J; Poso A; Nevalainen T
J Med Chem; 2008 Nov; 51(22):7057-60. PubMed ID: 18983140
[TBL] [Abstract][Full Text] [Related]
18. Identification of productive inhibitor binding orientation in fatty acid amide hydrolase (FAAH) by QM/MM mechanistic modelling.
Lodola A; Mor M; Rivara S; Christov C; Tarzia G; Piomelli D; Mulholland AJ
Chem Commun (Camb); 2008 Jan; (2):214-6. PubMed ID: 18092091
[TBL] [Abstract][Full Text] [Related]
19. A MBP-FAAH fusion protein as a tool to produce human and rat fatty acid amide hydrolase: expression and pharmacological comparison.
Labar G; Vliet FV; Wouters J; Lambert DM
Amino Acids; 2008 Jan; 34(1):127-33. PubMed ID: 17476568
[TBL] [Abstract][Full Text] [Related]
20. α-Ketoheterocycle inhibitors of fatty acid amide hydrolase: exploration of conformational constraints in the acyl side chain.
Duncan KK; Otrubova K; Boger DL
Bioorg Med Chem; 2014 May; 22(9):2763-70. PubMed ID: 24690529
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
